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Abstract
Background: The use of computerized clinical decision support systems (CCDSSs) may improve chronic disease
management, which requires recurrent visits to multiple health professionals, ongoing disease and treatment
monitoring, and patient behavior modification. The objective of this review was to determine if CCDSSs improve
the processes of chronic care (such as diagnosis, treatment, and monitoring of disease) and associated patient
outcomes (such as effects on biomarkers and clinical exacerbations).
Methods: We conducted a decision-maker-researcher partnership systematic review. We searched MEDLINE,
EMBASE, Ovid’s EBM Reviews database, Inspec, and reference lists for potentially eligible articles published up to
January 2010. We included randomized controlled trials that compared the use of CCDSSs to usual practice or non-
CCDSS controls. Trials were eligible if at least one component of the CCDSS was designed to support chronic
disease management. We considered studies ‘positive’ if they showed a statistically significant improvement in at
least 50% of relevant outcomes.
Results: Of 55 included trials, 87% (n = 48) measured system impact on the process of care and 52% (n = 25) of
those demonstrated statistically significant improvements. Sixty-five percent (36/55) of trials measured impact on,
typically, non-major (surrogate) patient outcomes, and 31% (n = 11) of those demonstrated benefits. Factors of
interest to decision makers, such as cost, user satisfaction, system interface and feature sets, unique design and
deployment characteristics, and effects on user workflow were rarely investigated or reported.
Conclusions: A small majority (just over half) of CCDSSs improved care processes in chronic disease management
and some improved patient health. Policy makers, healthcare administrators, and practitioners should be aware that
the evidence of CCDSS effectiveness is limited, especially with respect to the small number and size of studies
measuring patient outcomes.
Background
Chronic conditions present patients, practitioners, and
healthcare systems with some unique demands, includ-
ing recurrent visits, adherence to complex care plans,
long-term disease and treatment monitoring, behavior
modification, and patient self-management. For the
many patients with multiple co-morbidities [1],
overlapping or diverging care plans may further compli-
cate these processes.
Computerized clinical decision support systems
(CCDSSs) may help practitioners meet the requirements
of chronic care. These systems analyze a patient’sc h a r -
acteristics to provide tailored recommendations for diag-
nosis, treatment, patient education, adequate follow-up,
and timely monitoring of disease indicators. For exam-
ple, Holbrook et al.[ 2 , 3 ]g a v ep r o v i d e r sa n dd i a b e t i c
patients access to a web-based system that offered care
advice, allowed monitoring of diabetes risk factors, and
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tion, however, rigorous testing is warranted to deter-
mine whether CCDSSs improve chronic care processes
and patient outcomes.
In our previous review of the effects of CCDSSs [4],
we analyzed 100 randomized and non-randomized stu-
dies published until September 2004, 40 of which
assessed the effects of CCDSSs on disease management.
Of these 40 studies, 37 measured processes of care of
which 62% (23) showed an improvement, and 27 mea-
sured patient outcomes of which 19% (5) showed an
improvement. The quality of the studies varied widely,
but improved over time.
Many new randomized controlled trials (RCTs) have
been published in this field since our previous work,
potentially documenting important advances. Recogniz-
ing that the management of chronic disease has unique
characteristics, we wished to review the impact of
CCDSSs on the quality and effectiveness of chronic care.
We had the opportunity to include the perspectives of
senior hospital managers and front-line healthcare practi-
tioners to ensure that relevant data were extracted and
summarized–a level of stakeholder engagement that has
not been included in other reviews [5-8].
Methods
We previously published the details of our review proto-
col, openly accessible at http://www.implementa-
tionscience.com/content/5/1/12[9]. These methods are
briefly summarized here, along with details specific to
this review of CCDSSs for chronic disease management.
Research question
Do CCDSSs improve chronic disease management pro-
cesses or patient outcomes?
Partnering with decision makers
We conducted this review in partnership with indivi-
duals responsible for implementing CCDSSs in our
region [9]. Decision makers, both managers and clini-
cians, met with the review team periodically to discuss
direction and specific details for the data extraction,
analysis, presentation and interpretation of results.
Search strategy
Full details of our search strategy are in our review proto-
col [9]. In summary, we searched MEDLINE, EMBASE,
Ovid’s Evidence-Based Medicine Reviews, and Inspec until
6 January 2010, and reviewed the reference lists of
included RCTs and relevant systematic reviews. We
screened articles for eligibility in two stages: a duplicate,
independent review of titles and abstracts followed by a
duplicate, independent, full-text review of potentially eligi-
ble articles, with a third reviewer resolving disagreements.
Study selection
We selected RCTs of a CCDSS used by a health care
provider for management of chronic conditions, pub-
lished up to 6 January 2010 ina n yl a n g u a g et h a tm e a -
sured CCDSS impact on processes of care or patient
outcomes. We included RCTs in any language that com-
pared patient care with a CCDSS to routine care with-
out a CCDSS and evaluated clinical performance (i.e., a
measure of process of care) or a patient outcome. Addi-
tionally, to be included in the review, the CCDSS had to
provide patient-specific advice that was reviewed by a
healthcare practitioner before any clinical action. Studies
were excluded if the system was used solely by students,
only provided summaries of patient information, pro-
vided feedback on groups of patients without individual
assessment, only provided computer-aided instruction,
or was used for image analysis. Trials included in our
previous review [4] were included if they were eligible.
Trials of CCDSSs for managing narrow therapeutic
index medications used in some chronic conditions
(such as warfarin in atrial fibrillation [10]) were not
included in this review, but are discussed in our review
for therapeutic drug monitoring and dosing.
Data extraction
To meet the needs of our management and clinical part-
ners, we extracted study characteristics (e.g., study
design, size, setting, authorship, funding, and year of
publication) and system characteristics (e.g., integration
with other systems, user interface elements, methods of
data entry and delivery of recommendations, target
users, and implementation details such as pilot testing
and user training). Disagreements were resolved by a
third reviewer or by consensus. We contacted primary
authors to provide missing data and to assess the accu-
racy of the extracted data; 78% (43/55) provided input.
For the remaining trials, a trained reviewer assessed the
extraction form against the full-text to confirm accuracy.
Assessment of study quality
Using a 10-point scale, pairs of reviewers independently
evaluated the selected trials on five dimensions of qual-
ity, including concealment of allocation, appropriate
unit of allocation, appropriate adjustment for baseline
differences, appropriate blinding of assessment, and ade-
quate follow-up [9]. We used a 2-tailed Mann-Whitney
U test to compare methodologic scores between trials
published before the year 2000 and those published later
to determine if trial quality has improved with time.
Assessment of CCDSS intervention effects
We assessed the effectiveness of CCDSSs in each trial
for improving process of care and patient outcomes. We
defined process outcomes as changes in care activities
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Examples of patient outcomes included changes in
blood pressure, clinical events and health-related quality
of life. We judged a CCDSS effective if it produced a
statistically significant (p < 0.05) improvement in a pri-
mary chronic disease outcome or in ≥50% of multiple
relevant pre-specified outcomes. We considered primary
any outcome that trial reports described as ‘primary’ or
‘main.’ If authors did not designate a primary outcome,
we considered the outcome used to calculate the trial’s
sample size to be primary, if reported. When there were
no pre-specified outcomes, the system was considered
effective if it produced an improvement in ≥50% of all
reported chronic disease outcomes. Our assessment cri-
teria are more specific than those used in our 2005
review [4]; therefore, the assignment of effect was
adjusted for some trials included in the review.
Data synthesis and analysis
We summarized data using proportions, medians, and
ranges. Denominators vary in some proportions because
not all trials reported relevant information. All analyses
were carried out using SPSS, version 15.0. We did not
attempt a meta-analysis because of study-level differ-
ences in participants, clinical settings, disease conditions,
interventions, and outcomes measured.
We conducted a sensitivity analysis to assess the pos-
sibility of biased results in studies with a mismatch
between the unit of allocation (e.g., clinicians) and the
unit of analysis (e.g., individual patients without adjust-
ment for clustering). We compared success rates
between studies with matched and mismatched analyses
using chi-square for comparisons. No differences in
reported success were found for either process of care
outcomes (Pearson X
2 =1 . 4 1 ,p = 0.24) or patient out-
comes (Pearson X
2 = 1.45, p =0 . 2 3 ) .A c c o r d i n g l y ,
results have been reported without distinction for
mismatch.
Results
Figure 1 shows a flow diagram of included and excluded
trials. We identified 166 trials of CCDSSs and Cohen’s 
for reviewer agreement on trial eligibility was 0.93 (95%
confidence interval [CI], 0.91 to 0.94). In this review, we
included 71 publications describing 55 trials (33% of
total) about management of chronic diseases [2,3,11-79].
Thirty-eight included studies contributed outcomes to
both this review and other CCDSS interventions in the
series; three studies [30,53,62] to four reviews, 12 studies
[21,25,28,31-33,42-44,51,52,54,55,57-61,74] to three
reviews, and 23 studies [2,3,11,12,18,19,23,27,
35-38,40,41,45,46,48-50,56,67,71-73,77,79] to two
reviews; but we focused here on outcomes relevant to
the management of chronic disease.
Summary of trial quality is reported in Additional file
1, Table S1; system characteristics in Additional file 2,
Table S2; study characteristics in Additional file 3, Table
S3; outcome data in Table 1 and Additional file 4, Table
S4; and other CCDSS-related outcomes in Additional
file 5, Table S5.
Study quality
Additional file 1, Table S1 presents details of our meth-
odological quality assessment. Of the 55 trials, 53%
reported adequate concealment of allocation
[2,3,13,18,20,27,29,31-34,37,39,40,47-58,60-67,72-75];
78% showed no differences in baseline characteristics
between study groups or adjusted accordingly
[2,3,11-13,18-21,23-25,28,29,34,36,38-58,60-67,70-72,74-
76,78,79]; 53% allocated entire wards or practices to
each study group [11,12,14-18,25,28-35,37,39,46-
49,51,54-59,62-64,67,70,73,76-79]; all except one used
objective outcomes or blinding of outcome assessments
[23]; and 60% achieved a ≥90% follow-up rate for their
unit of analysis [11-13,18-24,27,30,35,36,39,40,46,
47,50-55,59-62,65-70,73,74,76,77]. The overall quality of
trials was good (median methods score, 8; ranging from
2 to 10) and improved with time (median methods
score before versus after year 2000, 7 versus 8, 2-tailed
Mann-Whitney U = 137; p = 0.005), possibly because
early trials often failed to conceal allocation or to
achieve adequate follow-up.
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Additional records identified from 
previous review (n = 86) and 
through other sources (n = 72) 
Records after duplicates removed 
(n = 14,188) 
Records screened 
(n = 14,188) 
Records excluded 
(n = 13,859) 
Full-text articles assessed 
for eligibility 
(n = 329) 
Full-text articles excluded, with 
reasons  (n = 163) 
74 Not RCTs 
50 Did not evaluate CCDSS 
14 Supplemental reports 
9 Severe methodological flaws 
7 Did not meet CCDSS definition 
4 Did not report outcomes of 
interest 
4 Only abstract published 
1 Included in previous review 
Studies included in review 
series 
(n = 166) 
Studies included in this 
review (met chronic 
disease management 
criteria) 
(n = 55) 
Figure 1 Flow diagram of included and excluded studies for
the update 1 January 2004 to 6 January 2010 with specifics
for chronic disease management*. * Details provided in: Haynes
RB et al. [9] Two updating searches were performed, for 2004 to
2009 and to 6 January 2010 and the results of the search process
are consolidated here.
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Study Methods
Score
Indication No. of
centres/
providers/
patients
Process of care outcomes CCDSS
Effect
a
Patient outcomes CCDSS
Effect
a
Diabetes
Holbrook, 2009
[2,3]
7 Web-based tracking of
diabetes monitoring in
adults in primary care.
18/46/511* Measurement of HbA1c, BP,
LDL-C, albuminuria, BMI,
exercise, and smoking
status; foot surveillance.
+ Levels of BP, LDL-C, HbA1c,
and albuminuria; BMI,
exercise rate, absence of
foot neuropathy and
smoking; quality of life.
+
Maclean, 2009
[11,12]
8 Reminders for the
management of diabetes in
primary care.
64*/132/
7,412
Test completion within
guideline-specified times
(HbA1c, lipids, serum
creatinine, and urine
microalbumin).
+ Mean HbA1c level; patients
with HbA1c <7%.
0
Christian, 2008
[13]
8 Patient feedback and
physician
recommendations for
management obesity and
type 2 diabetes in primary
care.
2/19/273* ... ... Weight change; patients
with ≥5% weight loss.
+
Cleveringa2008
[14-17]
6 Recommendations for
management of type 2
diabetes in primary care.
55*/
.../3,391
Diabetes treatment
satisfaction score.
0 Mean HbA1c. 0
Peterson, 2008
[18]
10 Visit reminders and patient-
specific physician alerts and
progress reports for
organization of primary
care in patients with type 2
diabetes.
24*/238/
7,101
Completion of foot and
eye exams, BP monitoring,
and renal, HbA1c, and LDL-
C tests.
+ Patients with target
composite clinical outcome
(SBP <130 mm Hg, HbA1c
<7%, and LDL-C <100 mg/
dL).
+
Quinn, 2008[19] 6 Cell phone-based type 2
diabetes management,
with real-time coaching for
patients and remote
monitoring of blood
glucose for practitioners in
primary care.
3/26/30* Medications intensified and
medication errors
identified.
+ Mean HbA1c. +
Augstein, 2007
[20]
8 Recommendations for
management of diabetes in
outpatients.
5/5/49* ... ... Change in HbA1c and
glucose levels.
+
Filippi, 2003[21] 7 Reminders for prescribing
of anti-platelet medications
to diabetic primary care
patients.
.../300*/
15,343
Patients with antiplatelet
drug prescriptions.
+ ... ...
Meigs, 2003[22] 6 Feedback for management
of type 2 diabetes in a
hospital-based internal
medicine clinic.
1/66*/598 Use of HbA1c and LDL-C
tests; BP measurement; eye
and foot exams.
0 Patients with HbA1c <7%;
change in HbA1c levels.
0
Lobach, 1997
[23]
6 Recommendations for
screening, monitoring, and
management of diabetes in
primary care.
1/58*/497 Compliance with diabetes
management
recommendations (foot,
ophthalmologic, and
complete physical exams;
chronic glycaemia
monitoring; urine protein
and cholesterol levels; and
influenza and
pneumococcal
vaccinations).
+ ... ...
Nilasena, 1995
[24]
7 Reminders for preventive
care activities in diabetic
outpatients.
2/35*/164 Compliance with
preventive care guidelines.
0 ... ...
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Mazzuca, 1990
[25]
7 Reminders generated from
the medical record system
and placed in patients’
clinic records for the
management of non-insulin
dependent diabetes
mellitus in outpatients.
4*/114/279 Adherence to five
recommendations for care
of non-insulin dependent
diabetes (HbA1c and fasting
blood glucose laboratory
orders, start home
monitoring of blood
glucose, diet clinic referral,
and start oral
hypoglycaemic therapy).
0 ... ...
Thomas, 1983
[26]
2 Recommendations for test
ordering, prescribing, and
early diagnosis for
ambulatory patients in
primary care.
1/.../185* Diabetic clinic visits. 0 Emergency department
visits; hospitalizations and
time hospitalized; BP and
glucose levels; obesity.
...
Diabetes and Other
Derose, 2005
[27]
7 Recommendations for
prescription of ACE-Is, ARBs,
and statins in outpatients
with diabetes or
atherosclerosis.
.../1089/
8,557*
Appropriate prescription of
ACE-Is, ARBs, or statins
within two weeks after
patient visit.
+ ... ...
Sequist, 2005
[28]
6 Reminders, based on
evidence-based guidelines,
for management of
diabetes and coronary
artery disease in primary
care.
20*/194/
6,243
Receipt of recommended
care for diabetes
(cholesterol, HbA1c, and
dilated eye exams, and use
of ACE-Is or statins) or
coronary artery disease
(cholesterol exam and use
of aspirin, beta-blockers,
and statins).
+ ... ...
Martin, 2004[29] 8 Alerts for management of
elderly patients in a health
maintenance organization
setting.
...*/104/
8,504
Disenrollment from Health
Management Organization
plan; patient satisfaction
with health plan.
+ General health (SF-36
score); inpatient and skilled
nursing facility admissions.
0
Demakis, 2000
[30]
7 Reminders for screening,
monitoring, and
counselling in accordance
with predefined standards
of care in ambulatory care.
12*/275/
12,989
Compliance with 13
standards of care for
coronary artery disease,
hypertension, diabetes,
smoking cessation,
vaccination, warfarin
treatment monitoring, atrial
fibrillation, myocardial
infarction, and
gastrointestinal bleeding.
+ ... ...
Hetlevik, 1999
[31-33]
8 Physician-initiated
guideline-based guidance
for diagnosis and
management of
hypertension, diabetes
mellitus, and
hypercholesterolemia in
primary care.
56*/56/
3,273
Hypertension and diabetic
patients without recorded
data for BP, serum
cholesterol, BMI, smoking
status, CHD risk score, and
CV inheritance; diabetic
patients without recorded
data for HbA1c levels.
0 SBP and DBP levels; serum
cholesterol levels; BMI;
change in smoking status;
change in CHD risk score
and proportion of patients
with CV inheritance; and,
for diabetic patients, HbA1c
levels.
0
Hypertension
Bosworth, 2009
[34]
9 Recommendations for
management of
hypertension in primary
care.
1*/32/588 ... ... Change in BP control. 0
Hicks, 2008[35] 7 Reminders for
management of
hypertension in adults in
primary care.
14*/
.../2,027
Visit-specific adherence to
guideline medication
prescribing.
+ Patients with controlled BP. 0
Roshanov et al. Implementation Science 2011, 6:92
http://www.implementationscience.com/content/6/1/92
Page 5 of 16Table 1 Results for CCDSS trials of chronic disease management (Continued)
Borbolla, 2007
[36]
7 Recommendations for
monitoring of BP in
outpatients and primary
care patients with chronic
disease.
.../182*/
2,315
BP measurement for
appropriate patients.
+ Mean SBP and DBP. 0
Mitchell, 2004
[37]
7 Feedback for identification,
treatment, and control of
hypertension in elderly
patients in primary care.
52*/
.../30,345
Patients without BP
measurements.
0 SBP levels; patients with
controlled hypertension.
0
Murray, 2004
[38]
5 Treatment
recommendations for
management of
hypertension in primary
care.
4/...*/712 Compliance with
antihypertensive drug
recommendations; patient
satisfaction with physicians
and pharmacists.
0 Quality of life measured
using SF-36 and a locally
validated generic quality of
life indicator.
0
Montgomery,
2000[39]
10 Computer support system
provided patient-specific
five-year CV risk for
management of
hypertension in primary
care.
27*/85/614 Number of patients
prescribed CV drugs.
0 Five-year CV risk; SBP; DBP. 0
Rossi, 1997[40] 9 Reminders to modify drug
therapy in hypertensive
outpatients receiving
calcium channel blockers.
1/71/719* Prescription changes from
a calcium channel blocker
to another antihypertensive
agent.
+. . .
McAlister, 1986
[41]
7 Feedback to physicians for
management of
hypertension in primary
care.
50/50*/
2,231
Length of follow up;
number of office visits;
patients treated for
hypertension.
0 Patients with DBP ≤90
mmHg; duration of DBP
≤90 mmHg; change in
DBP.
0
Rogers, 1984
[42-44]
4 Detection of deficiencies in
care and recommendations
for the management of
hypertension, obesity and
renal disease in outpatients.
1/.../484* Patients with hypertension
given renal function,
potassium, or fundoscopic
exams, or intravenous
pyelograms; number of
diets given to or reviewed
with obesity patients;
patients with renal disease
given renal function exams,
urine analysis, or urine
culture; perceived quality of
communication.
+ Perceived health status. +
Coe, 1977[45] 4 Recommendations for
management of
hypertension medication in
patients attending
hypertension clinics.
2/.../116* ... ... Adequate BP control. 0
Asthma and COPD
Fiks, 2009[46] 8 Alerts for influenza
vaccination for children
and adolescents with
asthma in primary care.
20*/
.../11,919
Captured opportunities for
vaccination; up-to-date
vaccination rates (adjusted
analysis).
0 ... ...
Poels, 2009[47] 10 Presentation of data to
assist in the diagnosis and
management of chronic
airway diseases in primary
care.
44*/.../868 Change in diagnoses. 0 ... ...
Martens, 2007
[48,49]
9 Recommendations for
appropriate use of
antibiotics and
management of asthma,
COPD, and dyslipidemia.
23*/53/
3,496
Appropriate prescribing or
lack of prescribing of drugs.
0 ... ...
Kattan, 2006[50] 8 Recommendations for
management of drug
therapy in severe asthma in
paediatric outpatients.
.../435/
937*
Time to appropriate
medication step-up; % of
scheduled visits within 2
months of medication step-
up recommendation.
+ Symptom days every 2
weeks.
0
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Kuilboer, 2006
[51]
10 Recommendations for
monitoring and treatment
of asthma and COPD in
primary care.
32*/40/
156,772
Contact frequency; peak
flow and FEV1
measurements; number of
prescriptions for respiratory
drugs.
0 ... ...
Plaza, 2005[52] 9 Guideline-based
recommendations to
general practitioners and
pneumologists for cost-
effective management of
asthma in primary care.
.../20*/198 Health resource use
(spirometry, blood tests,
total immunoglobulin E,
skin allergy tests, thorax
radiography, and oral
glucocorticoid
prescriptions); medical
visits; home visits; visits to
other physicians.
0 St. George Respiratory
Questionnaire total score.
+
Tierney, 2005
[53]
9 Recommendations for the
management of asthma
and COPD in adults in
primary care.
4/266*/706 Adherence to management
recommendations.
0 SF-36 subscale scores;
McMaster Asthma Quality
of Life Questionnaire
scores; McMaster Chronic
Respiratory Disease
Questionnaire scores;
emergency department
visits; hospitalizations.
0
Eccles, 2002
[54,55]
b
10 Care recommendations for
management of asthma
and angina in adults in
primary care.
62*/
.../4,506
Adherence to guideline
recommendations for
angina (record BP, 12-lead
and exercise
electrocardiogram, Hb and
lipid levels, blood glucose
levels, thyroid function, and
record or provide advice
for exercise, weight, and
smoking) and medications
prescribed for angina;
adherence to guideline
recommendations for
asthma (assessment of lung
function, compliance,
inhaler technique, and
smoking status, and
provision of asthma
education, action plan,
smoking cessation advice,
or nicotine replacement
therapy) and prescription of
drugs for asthma.
0 Quality of life (SF-36 and
EQ-5D questionnaires);
disease-specific quality of
life (Seattle angina
questionnaire, Newcastle
asthma symptoms
questionnaire, and the
asthma quality of life
questionnaire); angina or
asthma consultations.
0
McCowan2001
[56]
8 Guideline-based
recommendations for
management of asthma in
primary care.
...*/46/477 Practice initiated reviews;
peak flow meters issued;
self-management plans
used; symptom
assessments; prescriptions
for oral corticosteroids and
emergency nebulizations.
0 Acute asthma
exacerbations; patient-
initiated primary care
consultations.
+
Dyslipidemia
Bertoni, 2009
[57,58]
9 Recommendations for
guideline-consistent
screening and treatment of
dyslipidemia in primary
care.
59*/
.../3,821
Change from baseline in
number of patients with
appropriate lipid
management (based on
LDL-C and risk strata).
+ ... ...
Gilutz, 2009[59] 7 Reminders for monitoring
and treatment of patients
previously hospitalized with
coronary artery disease and
followed up in primary
care.
112*/600/
7,448
Appropriate initiation, up-
titration, or continuation of
statin therapy; rate of
adequate lipoprotein
monitoring.
+ Reduction in LDL-C. +
Lester, 2006
[60,61]
8 Recommendations, based
on evidence-based
guidelines, for the
management of patients at
high risk for hyperlipidemia
in primary care.
1/14/235* Patients with changes in
statin prescriptions at 1
month and 12 months.
+ Change in LDL-C. 0
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Cobos, 2005[62] 10 Recommendations for
hypercholesterolemia
therapy, follow-up visit
frequency, and laboratory
test ordering for patients
with hypercholesterolemia
in primary care.
42*/
.../2,221
Number of scheduled
physician visits and patient
assessments (lipids,
aspartate or alanine
aminotransferase, or
creatine kinase); number of
patients treated with lipid-
lowering drugs.
0 Patients successfully
managed according to CV
risk level assessed by LDL-C
levels or maintenance of
CV risk level.
0
Cardiac Care
Goud, 2009
[63,64]
8 Recommendations for
guideline-consistent care
plans for outpatient cardiac
rehabilitation.
35*/50/
2,787
Compliance with guideline
recommendations for
exercise training, education
therapy, relaxation therapy,
and lifestyle change
therapy.
+ ... ...
Feldman, 2005
[65,66]
9 Recommendations for
nurse-coordinated
management of patients
with heart failure receiving
home care.
.../354*/
628
Patient adherence to self-
management indicators
(taking and recognizing
medications, salting food,
and weighing behavior),
home-care related visits,
and outpatient doctor
visits.
0 Kansas City
Cardiomyopathy
Questionnaire and EuroQoL
EQ-5D scale scores;
depression (Geriatric
Depression Scale); service
use (hospitalizations,
inpatient nights, and
emergency department
visits).
0
Tierney, 2003
[67]
10 Guideline-based
recommendations for
management of heart
disease in primary care.
4*/115/706 Adherence with cardiac
care recommendations.
0 Quality of life (SF-36 scale
and chronic heart disease
questionnaire).
0
Eccles, 2002
[54,55]
b
10 Care recommendations for
management of asthma
and angina in adults in
primary care.
62*/
.../4,506
Adherence to guideline
recommendations for
angina (record BP, 12-lead
and exercise
electrocardiogram, Hb and
lipid levels, blood glucose
levels, thyroid function, and
record or provide advice
for exercise, weight, and
smoking) and medications
prescribed for angina;
adherence to guideline
recommendations for
asthma (assessment of lung
function, compliance,
inhaler technique, and
smoking status, and
provision of asthma
education, action plan,
smoking cessation advice,
or nicotine replacement
therapy) and prescription of
drugs for asthma.
0 Quality of life (SF-36 and
EQ-5D questionnaires);
disease-specific quality of
life (Seattle angina
questionnaire, Newcastle
asthma symptoms
questionnaire, and the
asthma quality of life
questionnaire); angina or
asthma consultations.
0
Other
Lee, 2009[68,69] 6 Recommendations for
screening, diagnosis and
obesity care planning in
acute and primary care.
.../29*/
1,874
Encounters with obesity-
related diagnoses or
missing obesity-related
diagnoses, and obesity
-related diagnoses not
screened and entered in
CCDSS.
+ ... ...
Locatelli, 2009
[70]
8 Recommendations for
management of chronic
kidney disease in
nephrology units.
53*/.../599 Use of iron therapy or
erythropoetic therapy;
guideline-adherent
treatment.
... Achievement of
hematological targets (Hb,
serum ferritin, hypochromic
red cell count); mean Hb
level.
0
Javitt, 2008[71] 6 Patient-specific
recommendations for
detecting and correcting
medical errors in a health
maintenance organization
setting.
1/1378/
49,988*
Resolution rate for
identified problems (add a
drug, do a test, or stop a
drug).
+ ... ...
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Verstappen
2007[72]
6 Management of
methotrexate for early
rheumatoid arthritis in
adult outpatients.
6/.../299* ... ... Patients in remission for ≥3
months in first two years.
+
Downs, 2006
[73]
9 Prompts for the
investigation and
management of dementia
in primary care.
35*/.../450 Detection of dementia;
compliance with diagnostic
guidelines.
0 ... ...
Feldstein,
2006b[74]
8 Guideline-recommended
osteoporosis care for 50-89
year old women in primary
care who experience a
fracture.
15/159/
311*
Measurement of bone
mineral density; use of
osteoporosis medication.
+ Caloric expenditure; regular
physical activity; calcium
intake.
0
McDonald2005
[75]
8 Recommendations to
home care nurses for
cancer pain assessment
and guideline-based
management.
1/336*/673 Nurse assessment practices
(pain, medications, mood,
and bowel movement);
nurse instruction practices
(medication and side effect
management, pain
management, contacting
physicians, and education);
cost-effectiveness for
reductions in pain and
hospitalizations.
0 Pain; quality of life
(European Organization for
Research and Treatment of
Cancer questionnaire);
symptom management;
cost-effectiveness.
0
Dexter, 1998
[76]
8 Reminders to discuss and
complete advanced
directives in outpatients.
4*/10/
1,042
Rate of advance directive
discussions; rate of form
completion.
+ ... ...
Rubenstein1995
[77]
7 Computer-generated
feedback designed to
identify and suggest
management for functional
deficits in primary care.
1*/73/557 Clinical problems listed at
visits; functional status
interventions for patients
with functional status
problems; physician
attitudes toward managing
functional status.
... Functional status (basic and
intermediate activities of
daily living, mental health,
social activities, and work
performance); specific
impairments (physical,
psychological, or social
function).
0
Petrucci, 1991
[78]
6 Recommendations for
nurse management of
urinary incontinence in
elderly patients in nursing
homes.
...*/50/27 Nurses’ knowledge about
urinary incontinence care.
+ Wet occurrences. +
McDonald1984
[79]
6 Reminders for
management of
outpatients, including
cancer screening,
vaccinations, and weight
reduction counselling.
1*/130/
12,467
Rate of clinician response
to indications for care
actions.
+ Hospitalizations; emergency
room and clinic visits; and
time averaged values for
DBP/SBP; weight; serum
glucose; serum Hb; serum
potassium; blood urea
nitrogen.
0
Abbreviations: ACE -I, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blockers; BMI, body mass index; BP, blood pressure; CCDSS,
computerized clinical decision support system; CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; CV, cardiovascular; DBP, diastolic
blood pressure; Hb, haemoglobin; LDL, low-density lipoprotein; SBP, systolic blood pressure.
*Unit of allocation.
aOutcomes are evaluated for effect as positive (+) or negative (-) for CCDSS, or no effect (0), based on the following hierarchy. An effect is defined as ≥ 50% of
relevant outcomes showing a statistically significant difference (2p < 0.05):
1. If a single primary outcome is reported, in which all components are applicable, this is the only outcome evaluated.
2. If >1 primary outcome is reported, the ≥50% rule applies and only the primary outcomes are evaluated.
3. If no primary outcomes are reported (or only some of the primary outcome components are relevant) but overall analyses are provided, the overall analyses
are evaluated as primary outcomes. Subgroup analyses are not considered.
4. If no primary outcomes or overall analyses are reported, or only some components of the primary outcome are relevant for the care area, any reported
prespecified outcomes are evaluated.
5. If no clearly prespecified outcomes are reported, any available outcomes are considered.
6. If statistical comparisons are not reported, ‘effect’ is designated as not evaluated (...).
bStudy included in two categories.
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Additional file 2, Table S2 describes CCDSS design and
implementation characteristics. Denominators vary
because not all trials reported on all features considered.
Fifty-nine percent (32/54) of CCDSSs were integrated
with electronic medical records [2,3,14-18,21-23,25,
26,28,29,31-40,42-44,46,48,49,51,53-55,60-64,67,73,74,76-
,79], and 17% (8/47) were also integrated with compu-
terized physician order entry systems [22,29,36,
38,46,48,49,53,60,61]. Fifty-three percent (25/47) auto-
matically obtained data needed to give recommendations
from electronic medical records [2,3,18,21-23,25,
28,34-36,38,40,46,48,49,51,53-55,60-64,67,73,74,76,79];
36% (17/47) relied on practitioners to enter the data
[2,3,14-17,23,30,39,41,45,48,49,52-58,67-69,72,75]; and
26% (12/47) used research staff for this purpose
[18,24,36,41,47,50,59,65,66,72,75,77,79]. Advice was pro-
vided at the time of care in 85% of trials (46/54)
[2,3,13-18,20-28,30-36,38-40,42-49,51-59,62-70,73-79]
most often on a desktop or laptop computer (51%; 26/
51) [2,3,14-17,21,22,28,30,34-39,46-49,51,53-56,62-64,67,
70,72-74] or by existing non-prescribing staff (22%; 11/
51) [18,23-26,30,40,42-44,71,76,79]. Fifty-three percent
(29/54) provided advice to other healthcare practitioners
in addition to physicians [2,3,11,12,14-18,22,23,25,26,
28-36,38,40,45-47,53,57-59,63,64,67,71,73,76,77,79] and
15% (8/55) directly advised patients in addition to prac-
titioners [2,3,11-13,18,19,29,41,74]. Sixty-four percent
(25/39) of systems were pilot tested [11-19,22,23,26,28,
31-34,36,37,39,46,47,50,51,56,59-61,63,64,67,72,77] and
healthcare professionals were trained to use them in
72% (34/47) [2,3,11-17,19-22,25,29-33,35,36,38,39,46-61,
63,64,67-69,73,77,78]. Reports rarely described the
CCDSS user interface characteristics.
Seventy-three percent of trials (40/55) declared that at
least one author was involved in the development of the
system
[2,3,11-13,18,19,22-26,28,30,34,36,38-51,53-61,63,64,67--
70,72,73,76,77,79] and three trials indicated that all
authors were independent of development [14-17,
31-33,78].
Additional file 3, Table S3 provides further details of
the CCDSS intervention, care setting, study funding
source, and year of publication. Trials included a total
of 7,335 practitioners (median, 72; ranging from 5 to
1,378 [when reported]) caring for 381,562 patients
(median, 719; ranging from 27 to 156,772 [when
reported]) in 974 clinics (median, 13; ranging from 1 to
112 [when reported]) across 705 distinct sites (median,
4; ranging from 1 to 112 [when reported]). Eight trials
did not report their source of funding [21,26,36,
40,71-73,75]. Of the remaining 47, 74% (n = 35) were
publicly funded, 17% (n = 8) were conducted with only
private funds, [14-17,19,27,48,49,52,60-62,70], and 9% (n
= 4) were conducted with a combination of private and
public funding [20,29,54,55,75]. The earliest trial was
published in 1977 [45], but over one-half (62%) were
published after our previous search in September 2004
[2,3,11-20,27-29,34-37,46-53,57-66,68-75].
CCDSS effects
Table 1 summarizes the effects of all systems for
improving process of care and patient outcomes and
Additional file 4, Table S4 provides further detail
regarding systems and individual outcomes selected for
evaluation.
Eighty-seven percent (48/55) of trials measured effects
on chronic disease management processes [2,3,11,12,
14-19,21-33,35-44,46-69,71,73-76,78,79], and 52% (25/
48) demonstrated improvement [2,3,11,12,18,19,
21,23,27-30,35,36,40,42-44,50,57-61,63,64,68,69,71,73,74-
,76,78,79]. Sixty-five percent (36/55) measured impact
on patient outcomes [2,3,11-20,22,29,31-39,
41-45,50,52-56,59-62,65-67,70,72,74,75,77-79] and 31%
(11/36) of these demonstrated benefit on measures such
as health-related quality of life, rates of hospitalization,
unscheduled care visits, and a host of disease-specific
clinical outcomes [2,3,13,18-20,42-44,52,56,59,72,78].
Diabetes
Thirteen trials described systems primarily supporting
diabetes care (median quality score, 7; ranging from 2 to
10) [2,3,11-26]. Fifty-five percent (6/11) reported
improvements in processes of care including treatment
and monitoring [2,3,11,12,18,19,21,23], while 62.5% (5/8)
reported improvements in corresponding patient out-
comes including blood pressure, HbA1c, and low-density
lipoprotein (LDL) cholesterol [2,3,13,18-20]. The seven
trials published since 2005 appeared to show success
more consistently: four of five improved the process of
care [2,3,11-13,18-20], and five of seven improved
patient outcomes [2,3,13,18-20].
S y s t e m si nf i v ed i a b e t e st r i a l st a r g e t e dp a t i e n t si n
addition to practitioners [2,3,11-13,18,19]. Of these, all
four trials that measured process effects demonstrated
benefit [2,3,11,12,18,19], and four reported improvement
in patient outcomes [2,3,13,18,19].
Several recent trials were conducted in primary
community clinics whereas most previous trials were
conducted in hospitals. For example, in two trials
conducted across multiple practices, CCDSSs pro-
vided patient-specific reminders during visits and
notified at-risk patients of their care targets and
upcoming appointments [2,3,11,18]. Both trials
demonstrated improvements in composite process
measures comprising timely completion of foot and
eye exams, and monitoring of blood pressure, HbA1c,
lipoproteins, and renal function. Both trials also
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patient outcomes.
Diabetes and other conditions
CCDSSs in five trials (median score, 7; ranging from 6
to 8) provided recommendations for a host of condi-
tions in conjunction with diabetes, including dyslipide-
mia, hypertension, obesity, and heart failure [27-33].
Their effects on diabetes outcomes could not be iso-
lated. All five measured process of care, and 80% (4/5)
found improvements [27-30]. Only one measured corre-
sponding patient outcomes, but showed no benefit
[31-33].
Hypertension
The 10 trials focusing primarily on hypertension
management (median score, 7; ranging from 4 to 10)
were older, with 70% (7/10) published before 2005
[34-45].
Eight of 10 trials assessed impact on process of care
using measures such as adherence to recommendations
for blood pressure control [35-44], patient satisfaction,
and number of scheduled care visits, and four demon-
strated improvements [35,36,40,42-44].
In contrast to diabetes systems, however, hypertension
systems showed little or no patient benefit. Of the nine
trials that reported patient outcomes, such as blood
pressure and health-related quality of life [34-39,41-45],
only one found benefit [42-44]. This multi-component
system improved patients’ perceived health status by
giving suggestions for the management of hypertension,
obesity, and renal disease. The trial, however, was of
poor quality (methods score 4), and the nature of the
intervention prevented isolating effects related to
hypertension.
Dyslipidemia
Four trials evaluated systems that focused primarily on
dyslipidemia [57-62]. All were conducted in primary
care settings and published after 2005 (median quality
score, 8.5; ranging from 7 to 10).
Three trials measured effects on process of care and
demonstrated improvements in lipid monitoring and
treatment [57-61], but only one of three trials mea-
suring patient outcomes found a benefit [59]. This
CCDSS generated patient-specific reminders that
were mailed to primary care physicians and nurses;
highlighted the patient’s risk factors, lipoprotein
values, and current medications; and recommended
initiation or adjustment of lipid-lowering treatment
when appropriate. The trial detected improvements in
blood lipid monitoring and treatment management, as
well as relative reductions in patients’ LDL
cholesterol.
Asthma and chronic obstructive pulmonary disease
(COPD)
The nine trials of systems supporting asthma care were
of excellent quality (median score, 9; ranging from 8 to
10) and relatively new (7/9 published after September
2004), but the systems were generally ineffective [46-56].
All trials measured effects on process of care (including
rates of spirometry, thorax radiography, IgE levels, and
allergy testing; medication prescriptions and influenza
vaccinations; and use of rescue medications) but only
one demonstrated benefit [50].
Two of five trials measuring patient outcomes found
an impact [52,56]. One system delivered asthma recom-
mendations in primary care, made prognostic predic-
tions by matching patients to similar known cases, and
allowed users to print self-management plans for their
patients [56]. The trial demonstrated a reduction in
acute asthma exacerbations and patient-initiated primary
care visits. Another system delivered guideline recom-
mendations to general practitioners and pneumologists,
and proved to be more cost effective at improving qual-
ity of life than usual asthma care [52].
Three asthma systems also gave advice for manage-
ment of COPD [48,49,51,53]. All of these measured pro-
cess of care but detected no effects. One trial also
measured patient outcomes but did not show benefit
[53].
Cardiac care
Systems in four methodologically strong trials (median
score, 9.5; ranging from 8 to 10) focused on heart failure
[65,66], cardiac rehabilitation [63,64], ischemic heart dis-
ease [67], and angina [54,55]. All measured process of
care using adherence to guideline recommendations but
only one found benefit [63,64]. The CCDSS for cardiac
rehabilitation used electronic medical records and needs
assessment data to generate recommendations for exer-
cise training, education, lifestyle change, and stress man-
agement [63,64]. The trial demonstrated improved
guideline adherence, but patient outcomes were not stu-
died. The other three trials measured effects on quality
of life as a patient outcome, but none found benefit
[54,55,65-67].
Other care
We did not group the remaining 12 trials due to their
diverse primary indications. They focused on urinary
incontinence [78], cancer [75], osteoporosis [74], renal
disease [70], functional deficits [77], obesity [68,69],
dementia [73], rheumatoid arthritis [72], advance direc-
tives [76], and various non-specific indications [71,79].
Most trials found improvements in care process but
only two demonstrated benefit to patients: one reduced
urinary incontinence in nursing home patients [78], and
Roshanov et al. Implementation Science 2011, 6:92
http://www.implementationscience.com/content/6/1/92
Page 11 of 16the other improved likelihood of remission in patients
with early rheumatoid arthritis through CCDSS-guided
management of methotrexate [72].
Costs and practical process related outcomes
Four trials used cost-effectiveness as an outcome (see
Additional file 4, Table S4) [14-17,52,65,66,75]. Only
one trial demonstrated improvement to patient out-
comes overall, and the CCDSS was also more cost-effec-
tive than usual asthma care [52].
Additional file 5, Table S5 summarizes cost-related
findings of the 12 trials that statistically compared costs
of care between the study groups: six reported no differ-
ence with CCDSS compared to usual care
[14-17,29,38,52,67,75], four reported savings with the
CCDSS [11,12,50,62,71], and two reported that the
CCDSS increased some costs [65-67].
In addition to process of care and patient outcomes,
we looked for effects on user satisfaction and workflow
(see Additional file 5, Table S5). Only seven trials
reported a formal effort of assessing user satisfaction: 3
found users satisfied overall [19,28,63,64], one found
them unsatisfied [54,55], and the remaining three
showed mixed results [2,3,31-33,56]. The authors of five
other studies commented that users were satisfied in
informal evaluations [13,18,36,59,72].
Two trials made formal attempts to measure systems’
impact on user workflow and reported mixed results
[23,63,64].
Discussion
This review was done in partnership with key decision
makers to summarize the effectiveness of clinical deci-
sion support technology for the management of chronic
conditions. We considered studies ‘positive’ if they
showed a statistically significant improvement in at least
50% of relevant outcomes. CCDSSs often improved the
process of patient care. When assessed, effects on any
patient outcomes were rarely found, but may have been
underestimated: 56% of trials reporting these outcomes
declared them primary
[11-20,22,29,34,35,38,50,52,56,59-62,67,70,72], and the
remaining trials may not have been large enough or
long enough to detect such outcomes. No study showed
convincing evidence of benefit for major patient
outcomes.
Nevertheless, results from recent diabetes manage-
ment trials are encouraging. Several of these systems
were deployed in general community practice and those
that engaged both patients and providers were consis-
tently effective. These systems may become increasingly
popular with the advent of patient-controlled electronic
medical records. Systems addressing several conditions,
including but not limited to diabetes, generally improved
care but only one measured patient outcomes [31-33]
(no effect). In dyslipidemia, systems improved lipid
monitoring and treatment, but only one reduced blood
lipids [59]. The few dyslipidemia trials were recent and
may represent a promising area for future research.
Conversely, most trials in hypertension measured
patient outcomes and almost never found benefits, and
only some showed improvements in the process of care.
Asthma and COPD systems mostly failed to show effec-
tiveness, despite being tested in recent, high-quality
trials. The small collection of trials in heart failure,
ischemic heart disease, cardiac rehabilitation, and angina
also rarely show effects, with improvement only in reha-
bilitation processes. The remaining systems, too diverse
to group, often improved care processes but were sel-
dom found to benefit patients.
While systems in diabetes appear to achieve success
with respect to patient outcomes more often than sys-
tems in asthma and hypertension, we did not pre-spe-
cify this comparison and, given the play of chance and
many possible confounders, we cannot confidently
assert that the pattern is real. It is plausible that the
effectiveness of CCDSS recommendations at improving
patient outcomes for some indications is limited by the
absence of high-quality clinical evidence in that area.
Even the most scientifically sound recommendations,
however, will fail to improve health outcomes if
patients do not adhere to prescribed treatments–av e r y
common problem [80]. Unfortunately, our suggestions
regarding the discrepancy remain purely speculative
because studies did not explore reasons for failure, and
we do not have enough trials to test these hypotheses
reliably.
T h eg r o w i n gu s eo fC C D S S sa n dt h e i rp o t e n t i a lf o r
benefit and harm highlight the importance of evaluating
these systems in well-conducted randomized clinical
trials. The increase in number and quality of trials is
encouraging, but results remain mixed, and few trials
investigated the mechanisms behind their findings. Care-
ful description of study and system design in trial
reports, as well as assessments of effectiveness and
acceptability of system features, would support progress
in this area.
CCDSSs may represent a cost-effective way of improv-
ing chronic disease outcomes. However, the economic
effects of systems are not readily assessed based on
available data. The costs of design, local implementation,
ongoing maintenance, and user support can be high,
and may be further elevated by the unique nature of
chronic care. This warrants cost-effectiveness analyses,
but only four trials [14-17,52,65,66,75] reported such
data and little cost data of any kind are available across
studies. If cost savings exist, however, current results
suggest that they are modest.
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terized decision support are not clear. Policy makers
promoting the use of CCDSS, as well as healthcare
administrators and practitioners considering local
implementation, should be aware that the evidence of
CCDSS effectiveness is limited, especially with respect
to the small number and size of studies of patient out-
comes. Further, evidence of benefit comes mainly from
af e w‘trail blazer’ institutions with much in-house
informatics expertise, evaluating home-grown systems
developed over many years. As a result, trials in this
review may not represent the effects in less technically
endowed settings or from commercially available sys-
tems, the capabilities of which have been shown to
vary greatly [81].
Our review has some potential limitations. Great het-
erogeneity in CCDSS design, purpose, and targets for
evaluation prevented us from conducting a meta-analy-
sis. Instead, we used a binary measure of effect, where
we considered studies ‘positive’ if they showed a statisti-
cally significant improvement in at least 50% of relevant
outcomes. Thus, some of the studies we considered to
show no effect found improvement on a minority of sec-
ondary or non-prespecified outcomes. These findings
could be real but could also be due to post hoc
unplanned analyses and multiple testing. Readers should
refer to the Methods section for a more detailed
account of our effect assessment.
We were unable to assess the risk of publication bias
in this literature. Given that most systems were studied
by their own developers, we suspect that publication
bias is likely, and even our findings of modest effects
may overestimate the true likelihood of seeing benefit
from CCDSSs.
Our method of summarizing the evidence by vote
counting inflates the risk of Type 2 error [82] and
should generally be approached with caution. However,
our results remain essentially unchanged from our
2005 review [4] and are comparable to another major
review conducted by Kawamoto and colleagues [83],
and a recent ‘umbrella ‘ review of high-quality sys-
tematic reviews of CCDSSs in hospital settings [84].
Another recent review of reminder systems [5] (a sub-
s e to fC C D S S )s u m m a r i z e de v i d e n c eb ye f f e c ts i z e
meta-analysis and qualified the impact of these inter-
ventions as falling below the thresholds of clinical
importance. Given the similar conclusions of these
other systematic reviews and the risk of publication
bias in the CCDSS literature, we have little reason to
believe that our methods underestimate the benefit
from these systems.
Finally, we observed improvements in the quality of
trials over time but this trend may have resulted from
better reporting in more recent studies.
Conclusions
CCDSSs can improve chronic disease management pro-
cesses and, in some cases, patient outcomes. Recent
trials in diabetes care show the most promising results.
The mechanisms behind systems’ success or failure
remain understudied. Future trials with clear descrip-
tions of system design, local context, implementation
strategy, costs, adverse outcomes, user satisfaction, and
impact on user workflow will better inform CCDSS
development and decisions about local implementation.
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